ZA973707B - Method for treating inflammation. - Google Patents

Method for treating inflammation.

Info

Publication number
ZA973707B
ZA973707B ZA9703707A ZA973707A ZA973707B ZA 973707 B ZA973707 B ZA 973707B ZA 9703707 A ZA9703707 A ZA 9703707A ZA 973707 A ZA973707 A ZA 973707A ZA 973707 B ZA973707 B ZA 973707B
Authority
ZA
South Africa
Prior art keywords
treating inflammation
inflammation
treating
Prior art date
Application number
ZA9703707A
Other languages
English (en)
Inventor
Sidney R Smith
Satwant K Narula
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA973707B publication Critical patent/ZA973707B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ZA9703707A 1996-05-03 1997-04-29 Method for treating inflammation. ZA973707B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/642,816 US5753218A (en) 1996-05-03 1996-05-03 Method for treating inflammation

Publications (1)

Publication Number Publication Date
ZA973707B true ZA973707B (en) 1997-10-29

Family

ID=24578143

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9703707A ZA973707B (en) 1996-05-03 1997-04-29 Method for treating inflammation.

Country Status (15)

Country Link
US (1) US5753218A (fr)
EP (1) EP0906118A1 (fr)
JP (1) JP2000509715A (fr)
KR (1) KR20000010706A (fr)
AR (1) AR006932A1 (fr)
AU (1) AU718857B2 (fr)
BR (1) BR9708908A (fr)
CA (1) CA2253312A1 (fr)
HU (1) HUP9903144A3 (fr)
ID (1) ID17194A (fr)
IL (1) IL126759A0 (fr)
NZ (1) NZ332464A (fr)
PE (1) PE64498A1 (fr)
WO (1) WO1997041882A1 (fr)
ZA (1) ZA973707B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US5800268A (en) 1995-10-20 1998-09-01 Molnick; Melvin Method of participating in a live casino game from a remote location
US7067144B2 (en) * 1998-10-20 2006-06-27 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation
MXPA01010480A (es) * 1999-04-13 2002-03-27 Schering Corp Usos novedosos de la proteina 0x2 de mamifero y reactivos relacionados.
US6544504B1 (en) 1999-07-28 2003-04-08 Schering Corporation Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy
WO2001008696A2 (fr) * 1999-07-28 2001-02-08 Schering Corporation Utilisation combinee d'interleukine 10 et de methotrexate pour therapie immunomodulatrice
WO2001008717A1 (fr) * 1999-08-03 2001-02-08 Smith & Nephew, Inc. Dispositifs implantables a liberation regulee
CA2431206C (fr) * 2000-12-08 2009-09-01 Takeda Chemical Industries, Ltd. Medicaments combines contenant un compose cycloalcene antisepticemique
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
WO2003030720A2 (fr) * 2001-10-09 2003-04-17 The Children's Hospital Of Philadelphia Matieres et methodes de prevention ou de diminution de la formation de cicatrices
WO2003045322A2 (fr) * 2001-11-28 2003-06-05 Schering Corporation Methode permettant de traiter et de prevenir la pancreatite
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US9511076B2 (en) * 2008-05-30 2016-12-06 Clarion Research Group Formulations and methods for recovery from dental surgery
US20120195938A1 (en) * 2007-05-30 2012-08-02 James Louis Rutkowski Formulations and methods for recovery from dental surgery
US20140294922A1 (en) * 2010-12-22 2014-10-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound with antibacterial activity
CA2928526A1 (fr) 2013-11-01 2015-05-07 Spherium Biomed S.L. Corps d'inclusion pour administration transdermique d'agents therapeutiques et cosmetiques
KR102624174B1 (ko) * 2020-09-18 2024-01-23 주식회사 아미코젠파마 수가용화된 담즙산을 포함하는 패혈증, 급성 폐손상 질환, 또는 급성 호흡곤란증후군의 예방 또는 치료용 약학 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
WO1989004838A1 (fr) * 1987-11-25 1989-06-01 Immunex Corporation Recepteurs d'interleukine-1
US5077284A (en) * 1988-12-30 1991-12-31 Loria Roger M Use of dehydroepiandrosterone to improve immune response
US5231012A (en) * 1989-06-28 1993-07-27 Schering Corporation Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)
EP0502080A4 (en) * 1989-11-21 1993-02-10 The University Of Melbourne Anti-inflammatory compositions and methods
US5300292A (en) * 1991-05-03 1994-04-05 The Regents Of The University Of California Composition and method for treating inflammation
ES2138976T3 (es) * 1991-08-06 2000-02-01 Schering Corp Uso de analogos o antagonistas de interleucina-10 para tratar la toxicidad inducida por endotoxinas o superantigenos.
US5368854A (en) * 1992-08-20 1994-11-29 Schering Corporation Use of IL-10 to treat inflammatory bowel disease
US5601815A (en) * 1992-08-21 1997-02-11 Schering Corp IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
CA2228620A1 (fr) * 1995-08-07 1997-02-20 John E. Oakes Traitement d'inflammations oculaires avec de l'interleukine-10

Also Published As

Publication number Publication date
CA2253312A1 (fr) 1997-11-13
HUP9903144A2 (hu) 2000-03-28
HUP9903144A3 (en) 2000-11-28
BR9708908A (pt) 1999-08-03
US5753218A (en) 1998-05-19
AU2808997A (en) 1997-11-26
NZ332464A (en) 2000-07-28
IL126759A0 (en) 1999-08-17
JP2000509715A (ja) 2000-08-02
PE64498A1 (es) 1998-10-29
KR20000010706A (ko) 2000-02-25
ID17194A (id) 1997-12-11
AR006932A1 (es) 1999-09-29
EP0906118A1 (fr) 1999-04-07
WO1997041882A1 (fr) 1997-11-13
AU718857B2 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
AU1527897A (en) Method for treating the prostate
AU2543097A (en) Method for treating pain
AU2587297A (en) Method for treating pain
AU3813397A (en) Apparatus for treating chondromalicia
ZA973707B (en) Method for treating inflammation.
GB9605828D0 (en) Treatment method
AU2340897A (en) Method for treating pain
PL328964A1 (en) Acne treating method
EP0843513A4 (fr) Procede de fonctionnement de dispositifs de montage
ZA972061B (en) New method.
GB9619758D0 (en) Method
ZA977625B (en) Tempering method.
GB9605709D0 (en) Method
ZA977867B (en) Method of treatment.
GB9624822D0 (en) Method
AU3740697A (en) Method for treating excessive aggression
AU4808397A (en) Method for treating cyanide poisoning
ZA972298B (en) Water treatment method.
GB9605482D0 (en) Method
ZA971775B (en) Novel method.
ZA979453B (en) Oncostatin M for treating inflammation
EP0667175A3 (fr) Méthode pour traiter les carres de skis etc.
AU2198997A (en) Method for treating insomnia
GB9619759D0 (en) Method
GB9600610D0 (en) Treatment method